Valsartan Tablets, USP, 160 mg, 90-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-5814-77.
Published December 19, 2018 · Recall initiated: November 20, 2018
Summary
FDA records drug Class II recall D-0314-2019, published December 19, 2018 and initiated November 20, 2018. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Ongoing; Reported quantity: 12,840 bottles; Lot: Lot # 3071352, exp. date 7/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.
What to do
Voluntary: Firm initiated · Press Release
Get an email if VALSARTAN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VALSARTAN
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Distributor
- Product was distributed throughout the United States.
- UPC
- 0303785815778
- Lot
- Lot # 3071352, exp. date 7/2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAValsartan Tablets USP 40 mg, 30 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJMarch 27, 2019
- FDAValsartan tablets USP 320 mg, 90-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc., Dayton,January 23, 2019
- FDAValsartan Tablets, USP 320 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
- FDAValsartan Tablets, USP 80 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
- FDAAmlodipine and Valsartan Tablets, USP,10 mg/160 mg, 30-count bottle, Rx Only, Made in India, Manufactured for:December 19, 2018
- FDAValsartan Tablets, USP, 40 mg, 30-count bottle, Rx Only, Made in India, Manufactured for: MylanDecember 19, 2018
Questions about this recall
Was Valsartan Tablets, USP, 160 mg, 90-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-5814-77. recalled?
Yes. FDA published recall D-0314-2019 on December 19, 2018. Reported hazard: CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VALSARTAN. UPC: 0303785815778.